This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Industries That May Never Have a Super Bowl Ad

Marijuana

On the federal level, nothing about marijuana policy has changed. It's still illegal for medical and recreational use.

On the state level, however, medical and not-so-medical marijuana are becoming voter-supported growth industries. Eighteen states and the District of Columbia have legalized the use of medical marijuana and turned it into a $17 billion industry. In November, Colorado and Washington voters helped legalize recreational pot use in their states.

Supporters of the ballot measures in those states say legalized marijuana will bring in tens of millions of dollars in revenue for state and local governments, with Colorado scheduled to open its first marijuana stores in January 2014. Publicly traded marijuana companies such as Medical Marijuana Inc. (MJNA), GrowLife Inc. (PHOT) and Hemp Inc. (HEMP) have already seen share prices surge.

Just one problem: The federal government still has a whole lot to say about regulation and taxation of weed and doesn't make it easy on dispensaries, shops and growers. Those folks have a tough time opening bank accounts for their businesses and would have an even tougher time keeping the feds off their back by taking out nationally televised ads. Especially during the Super Bowl, the biggest event for a sport with a weed history so cloudy that ESPN Magazine dedicated some serious real estate to discussing the topic in its NFL Draft issue last year.

Besides, even if weed was legal, it wouldn't be guaranteed air time. Just ask the Marlboro Man or Joe Camel what their Super Bowl Sunday plans are this year.

3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
CBS $61.59 -0.36%
CMCSA $57.87 0.57%
SAM $263.01 -0.22%
AAPL $132.54 0.88%
FB $80.54 0.07%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs